In contrast, overexpression of the constitutively active (T286D phosphomimetic mutant) form of CaMK2α significantly increased the growth, migration, and invasion capacities of MDA-MB-231 and MCF-7 breast cancer cells. The gene discussed is CAMK2A; the disease is breast cancer.